Aurora Private Wealth Inc. Acquires 6,729 Shares of Colgate-Palmolive Company (NYSE:CL)

Aurora Private Wealth Inc. lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 49.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,258 shares of the company's stock after buying an additional 6,729 shares during the period. Aurora Private Wealth Inc.'s holdings in Colgate-Palmolive were worth $1,898,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Norges Bank bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $912,375,000. Diamond Hill Capital Management Inc. purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $348,718,000. AMF Tjanstepension AB raised its holdings in Colgate-Palmolive by 1,088.8% during the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company's stock valued at $233,584,000 after acquiring an additional 2,353,268 shares during the period. Deutsche Bank AG raised its stake in shares of Colgate-Palmolive by 35.6% during the 4th quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock valued at $629,369,000 after purchasing an additional 1,816,865 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in Colgate-Palmolive during the 4th quarter worth about $132,405,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 0.1%

Shares of CL traded up $0.05 on Thursday, hitting $87.85. 5,813,551 shares of the stock traded hands, compared to its average volume of 4,787,750. Colgate-Palmolive Company has a one year low of $85.32 and a one year high of $109.30. The company has a market capitalization of $71.19 billion, a PE ratio of 24.82, a P/E/G ratio of 4.66 and a beta of 0.38. The business has a 50 day simple moving average of $91.14 and a 200 day simple moving average of $90.67. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter last year, the firm posted $0.86 EPS. The business's quarterly revenue was down 3.0% compared to the same quarter last year. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has approved a share repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board believes its shares are undervalued.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.76%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CL. Piper Sandler decreased their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Barclays decreased their target price on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. Finally, JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. One analyst has rated the stock with a sell rating, ten have given a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $101.69.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.